Severe aphthous stomatitis associated with oral calcineurin and mTOR inhibitors
- PMID: 20465622
- DOI: 10.1111/j.1365-4632.2009.04319.x
Severe aphthous stomatitis associated with oral calcineurin and mTOR inhibitors
Abstract
Background: Aphthous stomatitis, a common mucocutaneous disorder, is a well accepted complication of sirolimus therapy. This association has been reported less frequently with tacrolimus.
Case: We present an 11-year old male with Budd-Chiari syndrome who experienced profound worsening of chronic aphthous ulcers after immunosuppressive therapy was changed from tacrolimus to sirolimus.
Conclusion: Since these drugs are used widely in the pediatric transplantation population, this report serves to heighten awareness of this debilitating phenomenon, and to stress the importance of exercising caution when sirolimus and tacrolimus are administered in combination to pediatric patients.
Similar articles
-
mTOR inhibitor-associated dermatologic and mucosal problems.Clin Transplant. 2010 Mar-Apr;24(2):149-56. doi: 10.1111/j.1399-0012.2010.01232.x. Epub 2010 Mar 4. Clin Transplant. 2010. PMID: 20236129 Review.
-
Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients.Cancer. 2010 Jan 1;116(1):210-5. doi: 10.1002/cncr.24696. Cancer. 2010. PMID: 19862817
-
Sirolimus-induced aphthous ulcers which disappeared with conversion to everolimus.Saudi J Kidney Dis Transpl. 2008 Sep;19(5):819-20. Saudi J Kidney Dis Transpl. 2008. PMID: 18711306 No abstract available.
-
mTOR inhibitor/proliferation signal inhibitors: entering or leaving the field?J Nephrol. 2010 Mar-Apr;23(2):133-42. J Nephrol. 2010. PMID: 20155724 Review.
-
Reversible severe synovitis associated with everolimus.J Heart Lung Transplant. 2010 Jun;29(6):710-1. doi: 10.1016/j.healun.2010.01.001. Epub 2010 Feb 25. J Heart Lung Transplant. 2010. PMID: 20188596 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous